Thiotaurine Attenuates TNF-α-Induced Inflammation in Human Chondrocytes via NF-κB Pathway Suppression and Thiol-Dependent Persulfidation
International Journal of Molecular Sciences · 2025
DOI: 10.3390/ijms262010208 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2025. Verfasst von Alessia Mariano und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biochemical Sciences, Sapienza University of Rome, P.le Aldo Moro, 5, 00185 Roma, Italy. Hauptthemen laut MEDLINE: Chondrocytes, Tumor Necrosis Factor-alpha, NF-kappa B, Taurine. Die Arbeit nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Sapienza University of Roma.
Abstract (Originalsprache)
Thiotaurine (2-aminoethane thiosulfonate) is a naturally occurring sulfur-based compound featuring a thiosulfonate group, enabling it to act as a biologically relevant donor of hydrogen sulfide (H2S) through thiol-dependent persulfidation. H2S levels are known to be reduced in individuals with osteoarthritis, where it plays roles in modulating inflammation, oxidative stress, and pain. This study investigated the anti-inflammatory effects of Thiotaurine in human primary chondrocytes exposed to a pro-inflammatory cytokine. Cells were pre-treated with Thiotaurine prior to stimulation with TNF-α, and the expression levels of key interleukins were assessed at both the mRNA and protein levels. TNF-α stimulation led to upregulation of IL-6, IL-8, and IL-1β, which was significantly attenuated by Thiotaurine pre-treatment. Additionally, immunofluorescence analysis showed that Thiotaurine inhibited the phosphorylation and nuclear translocation of p65, indicating suppression of NF-κB pathway activation. Persulfide detection assays confirmed an increase in intracellular persulfide levels following Thiotaurine treatment. In summary, due to its anti-inflammatory activity and ability to release H2S, Thiotaurine emerges as a promising and potentially safe therapeutic option for osteoarthritis and other inflammation-related conditions.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Biochemical Sciences, Sapienza University of Rome, P.le Aldo Moro, 5, 00185 Roma, Italy.
- Department of Experimental Medicine and Rheumatology, William Harvey Research Institute, Queen Mary University of London, Charterhouse Square, London EC1M 6BQ, UK.
- Department of Bioscience and Technology for Food, Agriculture and Environment, University of Teramo, Via R. Balzarini 1, 64100 Teramo, Italy.
ORCID-Profile: Alessia Mariano, Irene Bigioni, Antonio Francioso, Anna Scotto d'Abusco, Mario Fontana
Förderung
- Sapienza University of Roma
Zitieren
APA
Mariano, A., Bigioni, I., Baseggio Conrado, A., Francioso, A., Scotto d'Abusco, A., & Fontana, M. (2025). Thiotaurine Attenuates TNF-α-Induced Inflammation in Human Chondrocytes via NF-κB Pathway Suppression and Thiol-Dependent Persulfidation. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms262010208
Vancouver
Mariano A, Bigioni I, Baseggio Conrado A, Francioso A, Scotto d'Abusco A, Fontana M. Thiotaurine Attenuates TNF-α-Induced Inflammation in Human Chondrocytes via NF-κB Pathway Suppression and Thiol-Dependent Persulfidation. International Journal of Molecular Sciences. 2025. doi:10.3390/ijms262010208
BibTeX
@article{Mariano2025,
author = {Mariano, Alessia and Bigioni, Irene and Baseggio Conrado, Alessia and Francioso, Antonio and Scotto d'Abusco, Anna and Fontana, Mario},
title = {Thiotaurine Attenuates TNF-α-Induced Inflammation in Human Chondrocytes via NF-κB Pathway Suppression and Thiol-Dependent Persulfidation},
journal = {International Journal of Molecular Sciences},
year = {2025},
doi = {10.3390/ijms262010208}
}
EUVIMED